Lakefront Biotherapeutics | GLPG - Spese Operative





Spese Operative Cambiamento Data
argenx SE USD 904M 10.57M 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Biogen USD 1.96B 69.6M 2026-03
Genmab DKK 798M 235M 2025-12
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.45B 255.28M 2026-03
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Incyte USD 5.62B 4.5B 2026-03
Merck EUR 4.09B 687M 2026-03
Neurocrine Biosciences USD 599.9M 22.3M 2026-03
Novartis USD 9.29B 507M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
UCB EUR 2.96B 196M 2025-12
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03